Form 4 Filing for BioStem Technologies, Inc.

This filing details a transaction by Steven D. Sonenreich, a director at BioStem Technologies, Inc. On August 27, 2026, Sonenreich acquired 7,671 shares of Common Stock through the vesting of 7,671 Restricted Stock Units. The transaction code is "M" (From/To reporting owner), and the acquired/disposed code is "A" (Payment for benefit or increase in holdings). The price per share was $0.00. Post-transaction, Sonenreich holds 7,671 shares of Common Stock. The filing also includes a Power of Attorney (Exhibit 24) appointing attorneys-in-fact to handle SEC filings on behalf of Steven D. Sonenreich, including Forms 3, 4, 5, and 144.